221 related articles for article (PubMed ID: 23643149)
1. Aplastic Anemia & MDS International Foundation (AA&MDSIF): bone marrow failure disease scientific symposium 2012.
Savage SA; Pulsipher MA; Romano A; Berlyne D
Leuk Res; 2013 Jul; 37(7):848-51. PubMed ID: 23643149
[TBL] [Abstract][Full Text] [Related]
2. Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010.
Malcovati L; de Latour RP; Risitano A
Leuk Res; 2011 Mar; 35(3):291-4. PubMed ID: 21036397
[TBL] [Abstract][Full Text] [Related]
3. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2014.
Visconte V; Lindsley RC; Berlyne D
Leuk Res; 2015 Jan; 39(1):110-3. PubMed ID: 25435026
[TBL] [Abstract][Full Text] [Related]
4. Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2018.
Becktell K; Berlyne D; Pagliuca S; Pommert L; Prata PH; Margolis D; de Latour RP; Dufour C; Pierri F
Leuk Res; 2019 May; 80():19-25. PubMed ID: 30908982
[TBL] [Abstract][Full Text] [Related]
5. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016.
Zeidan AM; Battiwalla M; Berlyne D; Winkler T
Leuk Res; 2017 Feb; 53():8-12. PubMed ID: 27923195
[TBL] [Abstract][Full Text] [Related]
6. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
Agarwal R; Chapple P; Brown M; Szer J; Juneja S
Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
[TBL] [Abstract][Full Text] [Related]
7. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
Passweg JR
Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
[TBL] [Abstract][Full Text] [Related]
8. [Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Makishima H
Rinsho Ketsueki; 2022; 63(9):1042-1045. PubMed ID: 36198527
[TBL] [Abstract][Full Text] [Related]
9. Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.
Escalante CP; Chisolm S; Song J; Richardson M; Salkeld E; Aoki E; Garcia-Manero G
Cancer Med; 2019 Feb; 8(2):543-553. PubMed ID: 30632713
[TBL] [Abstract][Full Text] [Related]
10. Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.
Donohue RE; Marcogliese AN; Sasa GS; Elghetany MT; Redkar AA; Bertuch AA; Curry CV
Cytometry B Clin Cytom; 2018 Jul; 94(4):699-704. PubMed ID: 28574201
[TBL] [Abstract][Full Text] [Related]
11. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
[TBL] [Abstract][Full Text] [Related]
12. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
[TBL] [Abstract][Full Text] [Related]
13. Killer immunoglobulin-like receptor genotype in immune-mediated bone marrow failure syndromes.
Howe EC; Wlodarski M; Ball EJ; Rybicki L; Maciejewski JP
Exp Hematol; 2005 Nov; 33(11):1357-62. PubMed ID: 16263420
[TBL] [Abstract][Full Text] [Related]
14. In vitro proliferation and differentiation of megakaryocytic progenitors in patients with aplastic anemia, paroxysmal nocturnal hemoglobinuria, and the myelodysplastic syndromes.
Cox CV; Killick SB; Patel S; Elebute MO; Marsh JC; Gordon-Smith EC; Gibson FM
Stem Cells; 2000; 18(6):428-34. PubMed ID: 11072031
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
Fattizzo B; Ireland R; Dunlop A; Yallop D; Kassam S; Large J; Gandhi S; Muus P; Manogaran C; Sanchez K; Consonni D; Barcellini W; Mufti GJ; Marsh JCW; Kulasekararaj AG
Leukemia; 2021 Nov; 35(11):3223-3231. PubMed ID: 33664463
[TBL] [Abstract][Full Text] [Related]
16. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.
Okamoto M; Shichishima T; Noji H; Ikeda K; Nakamura A; Akutsu K; Maruyama Y
Leukemia; 2006 Apr; 20(4):627-34. PubMed ID: 16467865
[TBL] [Abstract][Full Text] [Related]
17. [Gene mutations in bone marrow failure syndromes].
Yoshizato T; Makishima H
Rinsho Ketsueki; 2016; 57(12):2519-2525. PubMed ID: 28090021
[TBL] [Abstract][Full Text] [Related]
18. Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria.
Meletis J; Terpos E
Med Sci Monit; 2003 Jul; 9(7):RA161-72. PubMed ID: 12883466
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome.
Horikawa K; Nakakuma H; Kawaguchi T; Iwamoto N; Nagakura S; Kagimoto T; Takatsuki K
Blood; 1997 Oct; 90(7):2716-22. PubMed ID: 9326238
[TBL] [Abstract][Full Text] [Related]
20. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
Serio B; Selleri C; Maciejewski JP
Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
